PREMARKET ALERT: Human Genome Sciences (HGSI)

Posted in General 
July 22nd, 2009

Human Genome Sciences Inc. (Nasdaq: HGSI) shares are up nearly 4 percent to $14.39 in premarket trading of about 34,000 shares as of 7:30 a.m. Eastern. The company said the U.S. government has ordered an additional 45,000 doses of the company’s Abthrax vaccine to add to the Strategic National Stockpile. The company expects to receive about $151 million. Delivery is expected over three years, and will start near the end of 2009.
 – Mike Tarsala

Comments are closed

-->